UM

Browse/Search Results:  1-1 of 1 Help

Selected(0)Clear Items/Page:    Sort:
Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: Results from a randomized, placebo-controlled 4-week study Journal article
Hu Y.-D., Xiang Y.-T., Fang J.-X., Zu S., Sha S., Shi H., Ungvari G.S., Correll C.U., Chiu H.F.K., Xue Y., Tian T.-F., Wu A.-S., Ma X., Wang G.. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: Results from a randomized, placebo-controlled 4-week study[J]. Psychological Medicine, 2016, 46(3), 623.
Authors:  Hu Y.-D.;  Xiang Y.-T.;  Fang J.-X.;  Zu S.;  Sha S.; et al.
Favorite | TC[WOS]:109 TC[Scopus]:117 | Submit date:2018/10/30
Escitalopram  Ketamine  Key Words Efficacy  Major Depression  Response  Tolerability